Details of the Drug

General Information of Drug (ID: DMEVAOB)

Drug Name

Gemcabene

Synonyms

183293-82-5; UNII-B96UX1DDKS; B96UX1DDKS; 6-(5-Carboxy-5-methyl-hexyloxy)-2,2-dimethyl-hexanoic acid; Gemcabene [INN]; PD-72953; PD 72953; AC1L4IHZ; SCHEMBL761631; CHEMBL2110686; CTK4D8457; DTXSID60171407; SDMBRCRVFFHJKR-UHFFFAOYSA-N; ZINC1893031; PD72953; DB05123; ACM183293825; 6,6'-Oxybis(2,2-dimethylhexanoic acid); Hexanoic acid,6,6'-oxybis[2,2-dimethyl-; FT-0743032; 2,2,2',2'-Tetramethyl-6,6'-oxydihexanoic acid; 6-(6-hydroxy-5,5-dimethyl-6-oxohexoxy)-2,2-dimethylhexanoic acid; 6-(5-CARBOXY-5-METHYL-HEXOXY)-2,2-DIME

Indication

Disease Entry	ICD 11	Status	REF
Hypertriglyceridemia	5C80.1	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C16H30O5
Canonical SMILES: CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O
InChI: 1S/C16H30O5/c1-15(2,13(17)18)9-5-7-11-21-12-8-6-10-16(3,4)14(19)20/h5-12H2,1-4H3,(H,17,18)(H,19,20)
InChIKey: SDMBRCRVFFHJKR-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 157692
CAS Number: 183293-82-5
TTD ID: D0R4MT

Combinatorial Drugs (CBD)

Click to Jump to the Detailed CBD Information of This Drug

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)